471-480 of 664 results

CDR: What's next?
Insight 10 Sep 2018

The release of the exposure draft of the CDR legislation marks the start of a tight turnaround in order for the legislation to be passed in March 2019 particularly as the details and associated instruments have yet to be released The CDR regime has been advertised as producing a wide range of ...

Allens advises Healthscope on sale of medical centres business
News 05 Sep 2017

Allens has advised Healthscope Limited, one of Australia's leading private healthcare operators, on the sale of its Australian medical centres business to Fullerton Health, a leading provider of ...

Costs before Caution - Australia's unique approach to the interchangeability of biosimilars
Insight 17 Aug 2016

Recent developments in Australia suggest that there has been a deliberate prioritisation of the cost benefits of facilitating biosimilar interchangeability over the safety and efficacy risks that can arise when biosimilars are used interchangeably ...

NSW to bolster cyber security
Insight 05 Sep 2017

The NSW Government has recently announced a new $11.4 million investment to address emerging technology challenges including cyber security. ...

Predictive coding gets green light from an Australian court
Insight 09 Dec 2016

The Victorian Supreme Court recently handed down the first decision of an Australian court to specifically consider and approve the use of predictive coding technology in a large-scale discovery exercise Partner Nick Rudge Managing Associate Kate Austin and Applied Legal Technology Manager Lisa ...

Review your IP arrangements: IP exemption from competition laws soon to be repealed
Insight 12 Mar 2019

Section 51(3) of the Competition and Consumer Act 2010 (CCA), which currently exempts conditional licensing or assignment of IP rights from most of the prohibitions on anti-competitive conduct in the CCA, will be repealed. ...

Faster TGA disclosure - what it means for pharmaceutical patent litigation
Insight 23 Apr 2019

The TGA has consulted on whether it should disclose earlier that a prescription medicine is under evaluation and what types of prescription medicines should be published. ...

What do the Swiss and artificial sweetener have to do with patents?
Insight 18 Apr 2019

The recent Federal Court decision in Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd [2019] FCA 28 deals with fascinating issues for patentees seeking to enforce Swiss-style claims against makers of bioequivalent products. ...

BODalicious Instafamous stars come to litigious blows
Insight 22 Feb 2018

Two sporty insta-celebrities Sophie Guidolin and Rachael Finch have clashed over the alleged trademarked term 'Bod' and who gets to use it after. ...

Update on changes to Australia's IP laws
Insight 24 Apr 2018

Federal Parliament is considering a Bill to amend Australia's IP laws to implement some aspects of the Government's response to the Productivity Commission's (PC) inquiry into IP arrangements. IP Australia has also released its response to public consultation on several other of the PC's recommendat ...

Refine